Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Epirubicin 3Gemcitabine 2tislelizumab 1lornoxicam 1catumaxomab 1avelumab 1apatorsen 1VB4-845 1Ty21a typhoid vaccine 1Therapeutics 1Radiotherapy 1Postoperative Period 1Ofloxacin 1Multiparametric Magnetic Resonance Imaging 1Mitomycin 1Docetaxel 1Cystoscopy 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Non-Muscle Invasive Bladder Neoplasms × VB4-845 × Clear all
NCT04859751 2021-04-26

Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Qilu Pharmaceutical Co., Ltd.

Phase 3 Unknown
53 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡